<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2013-167-289-12182</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">SWE-2012-098:Reducing risks of emerging zoonoses to smallholders in sub-Saharan Africa: Rift Valley fever and Lassa fever at the human/livestock/wildl</narrative>
   <narrative xml:lang="SV">SWE-2012-098:Reducing risks of emerging zoonoses to smallholders in sub-Saharan Africa: Rift Valley fever and Lassa fever at the human/livestock/wildl</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The proposed post doctoral project will be part of an international, interdisciplinary consortium, Dynamic drivers of disease in Africa (DDDAC), with the aim to reduce risks of disease emergence and negative consequences for human wellbeing by studying the interactions between ecosystems, wildlife, domestic animals and human health. The objectives of this project is to focus on Rift Valley fever (RVF) in Kenya and Lassa fever in Sierra Leone, two emerging zoonotic diseases caused by two different viruses, vectored by arthropods and rodents respectively in two different ecosystems. By studying the epidemiology of RVF, important knowledge will be gained that may contribute to establishing an early warning system. The experiences of RVF epidemiology will further be a basis in the work on developing tools to assess the health, economic, social and environmental impact of Lassa fever virus.</narrative>
   <narrative xml:lang="SV">The proposed post doctoral project will be part of an international, interdisciplinary consortium, Dynamic drivers of disease in Africa (DDDAC), with the aim to reduce risks of disease emergence and negative consequences for human wellbeing by studying the interactions between ecosystems, wildlife, domestic animals and human health. The objectives of this project is to focus on Rift Valley fever (RVF) in Kenya and Lassa fever in Sierra Leone, two emerging zoonotic diseases caused by two different viruses, vectored by arthropods and rodents respectively in two different ecosystems. By studying the epidemiology of RVF, important knowledge will be gained that may contribute to establishing an early warning system. The experiences of RVF epidemiology will further be a basis in the work on developing tools to assess the health, economic, social and environmental impact of Lassa fever virus.</narrative>
  </description>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">University, college or other teaching institution, research institute or think-tank</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2013-02-13" type="1"></activity-date>
  <activity-date iso-date="2013-02-13" type="2"></activity-date>
  <activity-date iso-date="2014-12-31" type="3"></activity-date>
  <activity-date iso-date="2014-12-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="289" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">South of Sahara, regional</narrative>
  </recipient-region>
  <sector code="121" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Health, General</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Medical research</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2013-01-01"></period-start>
   <period-end iso-date="2013-12-28"></period-end>
   <value currency="USD" value-date="2013-01-01">122827.4887919916</value>
  </budget>
  <budget>
   <period-start iso-date="2014-01-01"></period-start>
   <period-end iso-date="2014-12-28"></period-end>
   <value currency="USD" value-date="2014-01-01">116619.775798481</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2013-02-13"></transaction-date>
   <value currency="USD" value-date="2013-02-13">245654.9775839833</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-01-28"></transaction-date>
   <value currency="USD" value-date="2014-01-28">116619.775798481</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
